Walgreens Boots Alliance, Inc. (WBA) Position Held by Archford Capital Strategies LLC

Archford Capital Strategies LLC continued to hold its position in shares of Walgreens Boots Alliance, Inc. (NASDAQ:WBA) during the first quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 1,589 shares of the pharmacy operator’s stock at the end of the first quarter. Archford Capital Strategies LLC’s holdings in Walgreens Boots Alliance were worth $132,000 at the end of the most recent reporting period.

Several other institutional investors and hedge funds also recently bought and sold shares of WBA. Waldron LP boosted its stake in shares of Walgreens Boots Alliance by 67.7% in the 1st quarter. Waldron LP now owns 4,500 shares of the pharmacy operator’s stock valued at $373,000 after purchasing an additional 1,816 shares in the last quarter. Personal Capital Advisors Corp boosted its stake in shares of Walgreens Boots Alliance by 42.1% in the 1st quarter. Personal Capital Advisors Corp now owns 4,833 shares of the pharmacy operator’s stock valued at $405,000 after purchasing an additional 1,433 shares in the last quarter. First Manhattan Co. boosted its stake in shares of Walgreens Boots Alliance by 2.3% in the 1st quarter. First Manhattan Co. now owns 131,830 shares of the pharmacy operator’s stock valued at $10,628,000 after purchasing an additional 2,909 shares in the last quarter. Sigma Planning Corp boosted its stake in shares of Walgreens Boots Alliance by 4.6% in the 1st quarter. Sigma Planning Corp now owns 10,703 shares of the pharmacy operator’s stock valued at $889,000 after purchasing an additional 469 shares in the last quarter. Finally, UMB Bank N A MO boosted its stake in shares of Walgreens Boots Alliance by 8.8% in the 1st quarter. UMB Bank N A MO now owns 14,216 shares of the pharmacy operator’s stock valued at $1,181,000 after purchasing an additional 1,150 shares in the last quarter. Institutional investors own 60.18% of the company’s stock.

Walgreens Boots Alliance, Inc. (NASDAQ WBA) traded up 1.14% on Tuesday, reaching $83.22. 3,328,019 shares of the company’s stock traded hands. The firm has a market cap of $89.05 billion, a PE ratio of 21.02 and a beta of 1.26. Walgreens Boots Alliance, Inc. has a 12 month low of $75.18 and a 12 month high of $88.00. The firm’s 50-day moving average is $80.85 and its 200 day moving average is $82.05.

Walgreens Boots Alliance (NASDAQ:WBA) last announced its quarterly earnings results on Thursday, June 29th. The pharmacy operator reported $1.33 EPS for the quarter, topping analysts’ consensus estimates of $1.30 by $0.03. Walgreens Boots Alliance had a return on equity of 17.34% and a net margin of 3.69%. The company had revenue of $30.12 billion during the quarter, compared to analyst estimates of $29.72 billion. During the same quarter last year, the firm posted $1.18 earnings per share. The firm’s revenue was up 2.1% on a year-over-year basis. Equities analysts predict that Walgreens Boots Alliance, Inc. will post $5.00 EPS for the current year.

Walgreens Boots Alliance announced that its Board of Directors has approved a share repurchase program on Thursday, June 29th that allows the company to repurchase $5.00 billion in shares. This repurchase authorization allows the pharmacy operator to buy up to 5.9% of its shares through open market purchases. Shares repurchase programs are usually a sign that the company’s leadership believes its stock is undervalued.

The firm also recently declared a quarterly dividend, which will be paid on Tuesday, September 12th. Investors of record on Friday, August 18th will be paid a $0.40 dividend. This is a positive change from Walgreens Boots Alliance’s previous quarterly dividend of $0.38. The ex-dividend date of this dividend is Wednesday, August 16th. This represents a $1.60 dividend on an annualized basis and a yield of 1.94%. Walgreens Boots Alliance’s dividend payout ratio (DPR) is presently 40.30%.

A number of equities research analysts have recently weighed in on WBA shares. Morgan Stanley restated an “overweight” rating and issued a $95.00 price target on shares of Walgreens Boots Alliance in a research note on Monday, July 3rd. BidaskClub upgraded shares of Walgreens Boots Alliance from a “sell” rating to a “hold” rating in a research note on Wednesday, August 30th. Citigroup Inc. restated a “buy” rating on shares of Walgreens Boots Alliance in a research note on Monday, July 3rd. Loop Capital started coverage on shares of Walgreens Boots Alliance in a research note on Thursday, August 24th. They issued a “buy” rating and a $95.00 price target on the stock. Finally, Guggenheim restated a “buy” rating on shares of Walgreens Boots Alliance in a research note on Monday, July 3rd. Two equities research analysts have rated the stock with a sell rating, three have issued a hold rating and fourteen have assigned a buy rating to the company. The stock presently has a consensus rating of “Buy” and an average target price of $91.81.

COPYRIGHT VIOLATION NOTICE: This piece was first reported by Sports Perspectives and is the sole property of of Sports Perspectives. If you are viewing this piece on another site, it was illegally stolen and reposted in violation of U.S. & international trademark & copyright laws. The legal version of this piece can be viewed at https://sportsperspectives.com/2017/09/12/walgreens-boots-alliance-inc-wba-position-held-by-archford-capital-strategies-llc.html.

In related news, Director William C. Foote sold 2,736 shares of the firm’s stock in a transaction on Tuesday, July 25th. The stock was sold at an average price of $79.79, for a total value of $218,305.44. Following the completion of the sale, the director now owns 19,151 shares of the company’s stock, valued at $1,528,058.29. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Company insiders own 13.50% of the company’s stock.

About Walgreens Boots Alliance

Walgreens Boots Alliance, Inc (Walgreens Boots Alliance) is a holding company. The Company is a global pharmacy-led, health and wellbeing enterprise. Walgreens Boots Alliance operates through three divisions, including Retail Pharmacy USA, Retail Pharmacy International and Pharmaceutical Wholesale. The Company’s products are marketed under a number of brands, which include No7, the Botanics range, Almus (generic medicines), Boots Pharmaceuticals and Soap & Glory (bathing and beauty brand).

Want to see what other hedge funds are holding WBA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Walgreens Boots Alliance, Inc. (NASDAQ:WBA).

Institutional Ownership by Quarter for Walgreens Boots Alliance (NASDAQ:WBA)

Receive News & Ratings for Walgreens Boots Alliance Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Walgreens Boots Alliance Inc. and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Leave a Reply